MULTICENTRE BRONCHIECTASIS STUDY: A Collaborative And International Study Of Bronchiectasis In Indigenous Children.
Funder
National Health and Medical Research Council
Funding Amount
$1,496,414.00
Summary
Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New ....Aboriginal children have repeated pneumonia episodes; some get better while others develop bronchiectasis (a chronic lung disease). The risk factors associated with progression to bronchiectasis, and the natural history of bronchiectasis in this population is little known. Given the similarities of these diseases among indigenous populations of affluent countries and to increase study size, a collaborative and international study of Indigenous children (Aboriginal and Torres Strait Islander, New Zealand Maori or Pacific Islander and Alaskan Native) has been initiated. In Indigenous children, we aim to define the natural history of chronic moist cough (those at risk of developing bronchiectasis) and bronchiectasis, identify the risk factors associated with progression from early-mild disease (chronic moist cough) to bronchiectasis and to define the role of continuous antibiotic treatment in the prevention of recurrent pulmonary infections that are very common in these children. We plan to follow up Aboriginal children aged 12 months to 8 years diagnosed with bronchiectasis or chronic moist cough. For those diagnosed with bronchiectasis, after fully informed consent is obtained from the parent(s), the child will be allocated by chance to one of the 2 treatment regimes: (1) Azithromycin once-week or (2) placebo once-week. Children will receive the medication or the placebo for a period of 24 months. All these children will be clinically seen 2x-year by the study's paediatrician and 2x-year by the research nurse for the duration of the study. By documenting, for the first time, the epidemiology and natural history of children with chronic moist cough and bronchiectasis, the study will provide a much-needed rationale for their management. If we can scientifically show that this is true, that Azithromycin is effective in reducing the number of respiratory infections, this would be an achievable advance in the treatment in the field for these children.Read moreRead less
The Extent And Impact Of Pharmaceutical Opioids For Chronic Non-cancer Pain
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
There have been dramatic increases in the use of pharmaceutical opioids (PO) for chronic non-cancer pain (CNCP), despite limited data on their long-term effectiveness and an increase in associated harm. This Fellowship provides critical new data to inform both clinicians and policymakers on the global extent of PO for CNCP, trajectories of problematic use and associated morbidity and a unique evaluation of the impact of real-time prescription monitoring program to reduce these harms.
InterLACE: International Collaboration For A Life Course Approach To Reproductive Health And Chronic Disease Events
Funder
National Health and Medical Research Council
Funding Amount
$495,965.00
Summary
Cardiovascular disease and diabetes are major chronic diseases among women. This world-leading research combines data from 7 international and 3 Australian studies of womenÍs health. We will investigate the relationship of reproductive health, from menarche to menopause, with the risk of Type 2 diabetes and cardiovascular disease in later life. Findings will support the development of policies and preventive health strategies to reduce the risk of these chronic diseases.
Understanding The Influence Of Agricultural Trade Policy On Food Consumption Patterns, Malnutrition, And Chronic Disease In Thailand And Australia
Funder
National Health and Medical Research Council
Funding Amount
$373,963.00
Summary
Trade policy is often developed without consideration of its effects on health. The Association of South-East Asian Nations (ASEAN) and New Zealand are key trading partners of Australia. Thus the ASEAN-Australia-New Zealand Free Trade Agreement (AANZFTA) was established in 2009. This project aims to analyse the effect of the agricultural trade component of the AANZFTA on food consumption patterns, malnutrition, obesity and chronic disease in Thailand and Australia.
Genetic And Environmental Risk Factors On Lifetime Risk Of Obstructive Lung Disease
Funder
National Health and Medical Research Council
Funding Amount
$351,414.00
Summary
Classification of lifetime phenotypes of obstructive lung disease allows investigation of the effect of environmental and genetic influences on specific phenotypes along with the interactions between them. Through improved phenotyping ,the currently inconsistent relationships between asthma and COPD and their associations with genetic and environmental factors may become clearer.
This project will investigate the causes of respiratory disease and poor lung function across the life course. Using existing lung health data from Australia and Europe, we will determine which behavioral, environmental, occupational, nutritional, other modifiable lifestyle, or genetic factors play a role in lung health. This research will enable the development of a personalised risk predictor application for implementation with patients and health care providers as well as the general public.
Large-scale Epidemiology, Chronic Disease And Disadvantaged Populations: Evidence And Translation
Funder
National Health and Medical Research Council
Funding Amount
$849,540.00
Summary
Nationally and internationally, we face an increasing burden of chronic disease and health care costs. Health risk factors and premature ill-health are increasingly concentrated in the disadvantaged. A large proportion of the chronic disease burden is preventable through better evidence and implementation. This application is to conduct innovative large-scale research on Indigenous health, chronic disease and the health of disadvantaged populations, including work on implementation of solutions.
My research focuses on allergies and chronic respiratory disease in children, teenagers and adults. My goal is to identify the factors, which cause these conditions and also the factors, which can stop these conditions from getting worse. I will work with health professionals and the community to make sure the results of my research are used by doctors to improve the care of people with allergies and chronic respiratory diseases.